Alterity Therapeutics (ATHE) Current Leases (2020 - 2026)

Alterity Therapeutics has reported Current Leases for 7 years, with the latest figure at $98096.5 in Q2 2026.

• On a quarterly basis, Current Leases rose 72.99% year-over-year to $98096.5 in Q2 2026; TTM through Jun 2026 was $98096.5, a 72.99% increase from a year earlier, with the FY2026 full-year figure at $98096.5, up 72.99% from the prior year.
• Current Leases was $98096.5 for Q2 2026 at Alterity Therapeutics, up from $42980.1 in the prior quarter.
• The five-year high for Current Leases was $98096.5 in Q2 2026, with the low at $519.14 in Q2 2024.
• Average Current Leases over 5 years is $40460.0, with a median of $42873.7 recorded in 2022.
• The sharpest annual moves came in 2023 and 2025: Current Leases sank 97.59% in 2023, then surged 10823.29% in 2025.
• Over 5 years, Current Leases stood at $42873.7 in 2022, then tumbled by 97.59% to $1032.1 in 2023, then jumped by 3873.72% to $41011.6 in 2024, then climbed by 4.8% to $42980.1 in 2025, then surged by 128.24% to $98096.5 in 2026.
• The last three Current Leases figures came in at $98096.5 (Q2 2026), $42980.1 (Q4 2025), and $56707.2 (Q2 2025), per Business Quant data.